Anxiety Clinical Trials in New York

Showing 61-61 of 61 trials

Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Generalized Anxiety Disorder

NCT00329264

The purpose of this study is to demonstrate that quetiapine SR (SEROQUEL®) is efficacious and safe in the acute treatment of patients with Generalized Anxiety Disorder. PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation was changed to XR after consultation with FDA.

Generalized Anxiety Disorder

AstraZeneca876 participantsStarted Apr 2006

Springdale, Arizona, United States • Little Rock, Arkansas, United States • Encino, California, United States +55 more locations

Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Generalized Anxiety Disorder

Anxiety Trials in Other Cities

Other Conditions in New York